TP53 and neoplasm: In the study of apoptosis-regulating proteins by Allal et al (2003), subgroup analysis revealed that patients with Bcl-2-positive/p53-negative anal tumours had significantly higher 5-year DFS compared with patients with tumours expressing all other combinations of these two proteins.